TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11403353

Group type: EXPERIMENTAL
Intervention: 50 mmol/day sodium chloride supplementation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 100 mmol/day sodium chloride supplementation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 200 mmol/day sodium chloride supplementation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 300 mmol/day sodium chloride supplementation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: AGT genotype modulation
Number of subjects: 46
Study: 9590488

Group type: EXPERIMENTAL
Intervention: 3-minute step test
Number of subjects: 85

Group type: COMPARATOR
Intervention: 6-minute walking test
Number of subjects: 85
Study: 7871114

Group type: EXPERIMENTAL
Intervention: Sheehan's Patient‐Rated Anxiety Scale
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Beck's Cognition Checklist
Number of subjects: 87
Study: 3139428

Group type: EXPERIMENTAL
Intervention: 0.25 mg sublingual nitroglycerin (Nitromex)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.50 mg sublingual nitroglycerin (Nitromex)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.75 mg sublingual nitroglycerin (Nitromex)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 0.5 mg sublingual nitroglycerin (Nitromex)
Number of subjects: 9

Group type: COMPARATOR
Intervention: 0.5 mg ordinary nitroglycerin
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31387119

Group type: EXPERIMENTAL
Intervention: Low fish oil (LFO) group (20% LC n‐3 PUFAs, 0.5 g/d)
Number of subjects: 5531

Group type: EXPERIMENTAL
Intervention: High fish oil (HFO) group (60% LC n‐3 PUFAs, 2.0 g/d)
Number of subjects: 5531

Group type: COMPARATOR
Intervention: Control (CON) group (0% LC n‐3 PUFAs, 0 g/d)
Number of subjects: 5531

Group type: EXPERIMENTAL
Intervention: Low fish oil (LFO) group
Number of subjects: 5531

Group type: EXPERIMENTAL
Intervention: High fish oil (HFO) group
Number of subjects: 5531
Study: 27225617

Group type: EXPERIMENTAL
Intervention: Oral dose of 50,000 IU vitamin D3 every week for 8 weeks, followed by 1 pearl every 2 weeks for 4 weeks (total of 3 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no vitamin D treatment)
Number of subjects: 40
Study: 25438724

Group type: EXPERIMENTAL
Intervention: Encenicline 1 mg oral capsule
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Encenicline 1 mg oral solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Encenicline 20 mg dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Encenicline 1-180 mg doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Encenicline (various doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Encenicline (1-180 mg)
Number of subjects: 0
Study: 23883525

Group type: EXPERIMENTAL
Intervention: Exercise rehabilitation program (intensive exercises in the ICU and the ward and as outpatients)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study: 21704313

Group type: EXPERIMENTAL
Intervention: Percutaneous E(2) (100 μg/24 h) during 2 weeks perimenstrually
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 19321996

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of prostate (HoLEP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 30
Study: 17039221

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Qigong
Number of subjects: 26
Study: 15112179

Group type: EXPERIMENTAL
Intervention: Doxercalciferol treatment
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: COMPARATOR
Intervention: Doxercalciferol treatment and Placebo
Number of subjects: 55
Study: 10778998

Group type: EXPERIMENTAL
Intervention: Antiplatelet treatment with ticlopidine (Group B)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Anticoagulant treatment with acenocoumarol (Group A)
Number of subjects: 404
Study: 9323513

Group type: EXPERIMENTAL
Intervention: L-Dopa treatment (ON)
Number of subjects: 15

Group type: COMPARATOR
Intervention: OFF L-Dopa
Number of subjects: 15
Study: 1610044

Group type: EXPERIMENTAL
Intervention: 60 mg pseudoephedrine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 3884576

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg)
Number of subjects: 0
Study: 31080168

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept 2 mg every 8 weeks for 52 weeks, after 5 initial doses every 4 weeks.
Number of subjects: 553
Study: 30284557

Group type: EXPERIMENTAL
Intervention: Oral edoxaban
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Subcutaneous dalteparin
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Subcutaneous dalteparin (in Select-D study)
Number of subjects: 1050
Study: 25960146

Group type: EXPERIMENTAL
Intervention: LA Sprouts intervention
Number of subjects: 319

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 319
Study: 23807272

Group type: EXPERIMENTAL
Intervention: MRKAd5 HIV‐1 gag/pol/nef vaccine
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Baseline risk behaviors (crack cocaine use, unprotected anal sex, drug use)
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Study enrollment
Number of subjects: 1134

Group type: EXPERIMENTAL
Intervention: Nonsterilized women
Number of subjects: 1134
Study: 22112610

Group type: EXPERIMENTAL
Intervention: C421A variant (CA+AA versus CC) in ABCG2
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: C421A variant in ABCG2
Number of subjects: 511

Group type: COMPARATOR
Intervention: Other variants in ABCB1 or ABCC2
Number of subjects: 511
Study: 19243824

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 810
Study: 17480139

Group type: EXPERIMENTAL
Intervention: Quyu Xiaoban capsules (QYXB) plus aspirin (300 mg loading dose, 100 mg maintenance dose) for 4 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Aspirin (300 mg loading dose, 100 mg maintenance dose) for 4 weeks
Number of subjects: 90
Study: 15228130

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide 5%/clindamycin 1% gel (BP/C)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 88
Study: 11754710

Group type: EXPERIMENTAL
Intervention: Rofecoxib, 25 mg/d
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Rofecoxib, 12.5 mg/d
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Celecoxib, 200 mg/d
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Acetaminophen, 4000 mg/d
Number of subjects: 382
Study: 9475649

Group type: EXPERIMENTAL
Intervention: Aerobic training (3-4 times per week for 30 min at 60% peak heart rate for 12 weeks, then 40-50 min at 75% peak heart rate for 12 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (yoga exercises over the same time period)
Number of subjects: 17
Study: 10609129

Group type: EXPERIMENTAL
Intervention: Current clinical protocols with in-hospital observation and discharge after several hours/days
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Dobutamine-atropine stress echocardiography performed between 0 and 18 hours after randomization
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Electrocardiographic exercise stress test performed between 0 and 18 hours after randomization
Number of subjects: 558
Study: 2069792

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 6658629

Group type: EXPERIMENTAL
Intervention: Cefoxitin (2 g intramuscularly)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Penicillin (4.8 X 10(6) units aqueous procaine penicillin G intramuscularly)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 406

Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 406
Study: 30211725

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 126

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 126
Study: 28933186

Group type: EXPERIMENTAL
Intervention: Alcohol media literacy (AML) intervention
Number of subjects: 165

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 165
Study: 26851469

Group type: EXPERIMENTAL
Intervention: Contoured foam
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Straight foam
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Wood
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: General ICM measurement
Number of subjects: 21
Study: 24249309

Group type: EXPERIMENTAL
Intervention: Postconditioning (PostC) during primary PCI
Number of subjects: 62
Study: 22784040

Group type: EXPERIMENTAL
Intervention: TDF-FTC (tenofovir disoproxil fumarate and emtricitabine)
Number of subjects: 2120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2120

Group type: EXPERIMENTAL
Intervention: TDF-FTC
Number of subjects: 2120
Study: 20383644

Group type: EXPERIMENTAL
Intervention: R (Strength training)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: E (Endurance training)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: CB (Combined training)
Number of subjects: 56
Study: 18175765

Group type: EXPERIMENTAL
Intervention: Glycemic index measurement of cheese-puffs
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Glycemic index measurement of fruit-leather
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Within-individual variation (refCV) for repeated reference food tests
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Mean laboratory GI
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Within-laboratory SD of GI
Number of subjects: 311
Study: 15910834

Group type: EXPERIMENTAL
Intervention: Chloramphenicol ointment applied at the surgical site at the end of procedure and 3rd day postoperatively
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no chloramphenicol ointment)
Number of subjects: 100
Study: 12795548

Group type: EXPERIMENTAL
Intervention: Happy mood induction (listening to classical music for 8 min)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sad mood induction (listening to classical music for 8 min)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 75
Study: 10221231

Group type: EXPERIMENTAL
Intervention: Desogestrel 75 micrograms
Number of subjects: 71

Group type: COMPARATOR
Intervention: Levonorgestrel 30 micrograms
Number of subjects: 71
Study: 7977145

Group type: EXPERIMENTAL
Intervention: Milk chocolate (280 g/d or 10 oz/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Milk chocolate (46.2 g or 1.65 oz)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isoenergetic substitution of one milk chocolate bar per day for a high-carbohydrate snack
Number of subjects: 0
Study: 2566781

Group type: EXPERIMENTAL
Intervention: Filtered blood (using 'Imugard IG500' filters)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Unfiltered blood
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Filtered blood (in very low birthweight infants)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Unfiltered blood (in very low birthweight infants)
Number of subjects: 72
Study: 165862

Group type: EXPERIMENTAL
Intervention: Neutral red photodynamic inactivation treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Phenol red (control)
Number of subjects: 19
Study: 30689757

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (IIV3)
Number of subjects: 7766

Group type: COMPARATOR
Intervention: Inactivated polio vaccine (IPV)
Number of subjects: 7766
Study: 29142090

Group type: EXPERIMENTAL
Intervention: Virtual Reality rehabilitation training (VR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional training (CT)
Number of subjects: 120
Study: 25769535

Group type: EXPERIMENTAL
Intervention: Surgical simulator training (n = 8)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Didactic training (n = 6)
Number of subjects: 14
Study: 23680854

Group type: EXPERIMENTAL
Intervention: Manual-guided CBT
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Manual-guided psychodynamic therapy
Number of subjects: 495

Group type: COMPARATOR
Intervention: Waiting list condition
Number of subjects: 495
Study: 20113526

Group type: EXPERIMENTAL
Intervention: Snoezelen therapy
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Structured reminiscence therapy
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 10-minutes activation
Number of subjects: 360

Group type: COMPARATOR
Intervention: Unstructured verbal communication
Number of subjects: 360
Study: 18221329

Group type: EXPERIMENTAL
Intervention: Exercise countermeasure during bed rest
Number of subjects: 16

Group type: COMPARATOR
Intervention: Bed rest-only
Number of subjects: 16
Study: 16614415

Group type: EXPERIMENTAL
Intervention: 50 g sesame seed powder daily for 5 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Rice powder placebo for 5 weeks
Number of subjects: 26
Study: 14516214

Group type: EXPERIMENTAL
Intervention: Recognition test (Test 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternate questions on Test 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2-test procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Process dissociation and remember-know procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Order of information access
Number of subjects: 0
Study: 11129729

Group type: EXPERIMENTAL
Intervention: Paclitaxel (Taxol) at escalating doses starting from 100 mg/m2 up to 250 mg/m2; Cremophor EL starting dose of 8.3 ml/m2 with increments of 2.1 ml/m2; Carboplatin dosages of 300, 350, or 400 mg/m2.
Number of subjects: 39
Study: 8793497

Group type: EXPERIMENTAL
Intervention: GnRH analogue (goserelin) + oral contraceptive (OC) containing ethinyl estradiol and cyproterone acetate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral contraceptive (OC) containing ethinyl estradiol and cyproterone acetate
Number of subjects: 0
Study: 1546145

Group type: EXPERIMENTAL
Intervention: moclobemide 150-150-150 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: toloxatone 400-200-400 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 3987183

Group type: EXPERIMENTAL
Intervention: Meptazinol 50 mg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Meptazinol 100 mg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Meptazinol 200 mg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Morphine 4 mg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Morphine 8 mg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Morphine 16 mg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Meptazinol
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Mood improvement and overall satisfaction
Number of subjects: 102
Study: 31609297

Group type: EXPERIMENTAL
Intervention: EX (exercise)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: EX+CO2 (exercise + hypercapnic gas)
Number of subjects: 17
Study: 29709732

Group type: EXPERIMENTAL
Intervention: Low Threshold Intervention (LTI)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Voucher Reinforcement Intervention (VRI)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Standard Care Intervention (SCI)
Number of subjects: 212
Study: 26268482

Group type: EXPERIMENTAL
Intervention: BP-SES (sirolimus eluting stent with bioresorbable polymer)
Number of subjects: 194

Group type: COMPARATOR
Intervention: PP-EES (everolimus eluting stent with permanent polymer)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: BP-SES
Number of subjects: 194

Group type: COMPARATOR
Intervention: PP-EES
Number of subjects: 194
Study: 24875810

Group type: EXPERIMENTAL
Intervention: Buttressed stapler (B group)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Non-buttressed stapler (non-B group)
Number of subjects: 76
Study: 22184720

Group type: EXPERIMENTAL
Intervention: Maggot debridement therapy (MDT)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 119
Study: 20676860

Group type: EXPERIMENTAL
Intervention: Topical lanolin ointment (PureLan)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Bovine type I collagen spray (Gelfix)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no topical treatment)
Number of subjects: 71
Study: 18565251

Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronic acid (HA) injections (3 injections with one-week interval)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Exercise therapy (6 weeks)
Number of subjects: 30
Study: 16006900

Group type: EXPERIMENTAL
Intervention: Buscopan
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study: 12236885

Group type: EXPERIMENTAL
Intervention: 3% 2-dimethylaminoethanol (DMAE) gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control formulation without DMAE
Number of subjects: 30
Study: 10379746

Group type: EXPERIMENTAL
Intervention: Bilateral varicocelectomy
Number of subjects: 91

Group type: COMPARATOR
Intervention: Unilateral varicocelectomy
Number of subjects: 91
Study: 7536438

Group type: EXPERIMENTAL
Intervention: Intradermal recombinant human TNF-alpha (rHuTNF-alpha) 100 U (group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intradermal recombinant human TNF-alpha (rHuTNF-alpha) 5000 U (group B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intradermal recombinant human TNF-alpha (rHuTNF-alpha) 100 U daily for 5 days (group C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (100 U and 5000 U, single injections; 100 U, multiple injections)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 1665184

Group type: EXPERIMENTAL
Intervention: Lisinopril-hydrochlorothiazide (L/HCTZ) 20 mg/12.5 mg
Number of subjects: 278
Study: 6752873

Group type: EXPERIMENTAL
Intervention: Pirprofen (1000 mg/day)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Indomethacin (125 mg/day)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 30597541

Group type: EXPERIMENTAL
Intervention: Moderate disclosure of therapist's personal experience with the same psychological problem
Number of subjects: 104

Group type: COMPARATOR
Intervention: No disclosure of therapist's personal experience with the same psychological problem
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Mild disclosure of therapist's personal experience with the same psychological problem
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Extreme disclosure of therapist's personal experience with the same psychological problem
Number of subjects: 104
Study: 28600154

Group type: COMPARATOR
Intervention: Continuous positive airway pressure group
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Surfactant group
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Successful extubation
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Failed extubation
Number of subjects: 1071
Study: 27023596

Group type: EXPERIMENTAL
Intervention: Elderberry extract (Sambucus nigra L.)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study: 25189288

Group type: EXPERIMENTAL
Intervention: Repositioning every 2 hours
Number of subjects: 329

Group type: COMPARATOR
Intervention: Repositioning every 4 hours
Number of subjects: 329
Study: 21039353

Group type: EXPERIMENTAL
Intervention: Chloroprocaine 40 mg (20 mg/ml)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Articaine 60 mg (40 mg/ml)
Number of subjects: 78
Study: 19897500

Group type: EXPERIMENTAL
Intervention: Left ventricular (LV) apical pacing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Right ventricular (RV) apical pacing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: RV free wall pacing
Number of subjects: 32
Study: 17392739

Group type: EXPERIMENTAL
Intervention: 17.5 mg hydrocortisone (cortisol)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 14760661

Group type: EXPERIMENTAL
Intervention: 800 ml of an iso-osmolar 12.5 percent carbohydrate-rich beverage (100 g carbohydrate) the evening before operation and another 400 ml (50 g carbohydrate) 2 hours before anaesthesia.
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo beverage (same volume as the intervention).
Number of subjects: 94
Study: 11918251

Group type: EXPERIMENTAL
Intervention: Sustained release metoprolol 95 mg
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 9439530

Group type: EXPERIMENTAL
Intervention: Copper supplementation (2 mg/d for 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Copper supplementation
Number of subjects: 20
Study: 7513853

Group type: EXPERIMENTAL
Intervention: Tandem method
Number of subjects: 56

Group type: COMPARATOR
Intervention: Simple sequential method
Number of subjects: 56
Study: 3428132

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 100 mg/kg (max 4 g) intravenously (i.v.) once daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ampicillin i.v. 160 mg/kg/day plus chloramphenicol i.v. 100 mg/kg/day every 6 h
Number of subjects: 30
Study: 31325040

Group type: EXPERIMENTAL
Intervention: Wheat germ-enriched bread (6 g of wheat germ)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Non-enriched wheat bread
Number of subjects: 55
Study: 28357972

Group type: EXPERIMENTAL
Intervention: Psychological intervention for patient-caregiver dyads as part of home-based specialized palliative care (Domus model)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychological intervention
Number of subjects: 0
Study: 26024551

Group type: EXPERIMENTAL
Intervention: 6.4% carbohydrate solution (CHO)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 6.4% carbohydrate and 4 mg/kg caffeine (C+C)
Number of subjects: 12

Group type: COMPARATOR
Intervention: water (PLA)
Number of subjects: 12
Study: 25288141

Group type: EXPERIMENTAL
Intervention: PAIR-UP intervention
Number of subjects: 638

Group type: COMPARATOR
Intervention: UC
Number of subjects: 638
Study: 23919853

Group type: EXPERIMENTAL
Intervention: Foley catheter and synchronous low dose intravaginal misoprostol
Number of subjects: 3

Group type: COMPARATOR
Intervention: Foley catheter alone
Number of subjects: 3

Group type: COMPARATOR
Intervention: Low dose intravaginal misoprostol alone
Number of subjects: 3
Study: 21097434

Group type: EXPERIMENTAL
Intervention: Cerebral State Index (CSI) during target controlled infusion (TCI) of propofol
Number of subjects: 40